U.S. FDA Approves Kesimpta® (ofatumumab) in Relapsing Multiple Sclerosis
Company Announcement Kesimpta® (ofatumumab) approved by U.S. FDA for the treatment of relapsing forms of multiple sclerosis in adults First B-cell therapy that can be self-administered using Sensoready® autoinjector pen Approval based on Phase III …